taccetti.qxp 7/8/09 4:11 pm Page 58
Cystic Fibrosis
1. Ratjen F, Döring G, Cystic fibrosis, Lancet, 2003;22(361): infections caused by community-acquired methicillin- Staphylococcus aureus, J Clin Microbiol, 2000;38:1008–15.
681–9. resistant Staphylococcus aureus, Clin Infect Dis, 2008;46: 38. Taccetti G, Neri AS, Cocchi P,et al., Methicillin-resistant
2. Döring G, Hoiby N, Early intervention and prevention of 368–77. Staphylococcus aureus (MRSA) in cystic fibrosis patients:
lung disease in cystic fibrosis: a European Consensus, 23. Rossney AS, Shore AC, Morgan PM, et al., The prevalence and clinical findings, Pediatr Pulmonol,
J Cyst Fibros, 2004;3:67–91. emergence and importation of diverse genotypes of 2008;(Suppl. 31):343, abstract 397.
3. Cystic Fibrosis Foundation, Patient Registry 2006 Annual methicillin-resistant Staphylococcus aureus (MRSA) 39. Thomas RS, Gyi HG, Hodson ME, Methicillin-resistant
report, Bethesda, Maryland. harboring the Panton-Valentine leukocidin gene (pvl) Staphylococcus aureus, impact at a national cystic fibrosis
4. Boucher HW, Corey GR, Epidemiology of methicillin- reveal that pvl is a poor marker for community-acquired centre, J Hosp Infect, 1998;40:203–9.
resistant Staphylococcus aureus, Clin Infect Dis, 2008;46: MRSA strains in Ireland, J Clin Microbiol, 2007;45: 40. Solis A, Brown D, Hughes J et al., Methicillin-resistant
344–9. 2554–63. Staphylococcus aureus in children with cystic fibrosis: an
5. Lowy FD, Staphylococcal infections. In: Fauci AS, 24. Methicillin-resistant Staphylococcus aureus (MRSA) eradication protocol, Pediatr Pulmonol, 2003;36:189–95.
Braunwald E, Kasper DL, et al. (eds), Harrison’s Principles of infections. Fact sheet for healthcare providers (update 41. Boyle MP, Ross T, Casewell MW, et al., Molecular
internal Medicine 17th ed, New York: McGraw Hill, 2/19/08), Health Care Agency Pubblic Health Services, epidemiology of MRSA infection in cystic fibrosis and its
2008:872–81. Epidemiology and Assesment. Available at: clinical implications, Pediatr Pulmonol, 2005;(Suppl. 28):
6. American Academy of Pediatrics, Staphylococcal www.lapublichealth.org/acd/docs/CAMRSA_ProviderFac 288, abstract 286.
Infections. In: Pickering LK, Baker CJ, Long SS, McMillan tSheet.pdf (accessed 1 November 2008). 42. Ren CL, Morgan WJ, Konstan MW, et al., Presence of
JA (eds), Red Book: 2006 Report of the Committee on Infectious 25. Campana S, Taccetti G, Ravenni N, et al., Molecular methicillin-resistant Staphylococcus aureus in respiratory
Disease, 27th ed, Elk Grove Village, IL: American Academy epidemiology of Pseudomonas aeruginosa, Burkholderia cultures from cystic fibrosis patients is associated with
of Pediatrics, 2006:598–610. cepacia complex and methicillin-resistant Staphylococcus lower lung function, Pediatr Pulmonol, 2007;42:513–18.
7. David MZ, Glikman D, Crawford SE, et al., What is aureus in a cystic fibrosis center, J Cyst Fibros, 2004;3: 43. Boxerbaum B, Jacobs MR, Cechner RL, Prevalence and
community-associated methicillin-resistant 159–63. significance of methicillin-resistant Staphylococcus aureus
Staphylococcus aureus?, J Infect Dis, 2008;197:1235–43. 26. Glikman D, Siegel JD, David MZ, et al., Complex in patients with cystic fibrosis, Pediatr Pulmonol,
8. Flynn N, Cohen SH, The continuing saga of MRSA, J Infect molecular epidemiology of methicillin resistant 1988;4(3):159–63. Erratum in: Pediatr Pulmonol,
Dis, 2008;197:1217–19. Staphylococcus aureus isolates from children with cystic 1988;5(1):66.
9. Cystic Fibrosis Trust, Methicillin-resistant Staphylococcus fibrosis in the era of epidemic community-associated 44. Garske LA, Kidd TJ, Gan R, et al., Rifampicin and sodium
aureus (MRSA), Report of the UK Cystic Fibrosis Trust methicillin resistant S. aureus, Chest, 2008;133:1381–7. fusidate reduces the frequency of methicillin-resistant
Infection Control Working Group, Cystic Fibrosis Trust. 27. Vergison A, Denis O, Deplano A, et al., National survey of Staphylococcus aureus (MRSA) isolation in adults with
Available at www.cftrust.org.uk/aboutcf/publications/ molecular epidemiology of Staphylococcus aureus cystic fibrosis and chronic MRSA infection, J Hosp Infect,
consensusdoc/ (accessed 1 November 2008). colonization in Belgian cystic fibrosis patients, 2004;56:208–14.
10. Stone A, Saiman L, Update on the epidemiology and J Antimicrob Chemother, 2007;59:893–9. 45. Elizur A, Orscheln RC, Ferkol TW, et al., Transmission of
management of Staphylococccus aureus, including 28. Campana S, Project Title: Community aquired-MRSA and Panton-Valentine leukocidin-positive Staphylococcus aureus
methicillin-resistant Staphylococccus aureus, in patients hospital aquired MRSA in Cystic fibrosis patients: a between patients with cystic fibrosis, J Pediatr, 2007;151:
with cystic fibrosis, Curr Opin Pulm Med, 2007;13:515–21. multicenter study regarding national and global 90–92.
11. Dasenbrook EC, Merlo CA, Diener-West M, et al., epidemiology, antibiotic susceptibility, natural history 46. Orens JB, Estenne M, Arcasoy S, et al., International
Persistent methicillin-resistant Staphylococccus aureus and and clinical relevance. Project FFC #11/2007. Available guidelines for the selection of lung transplant
rate of FEV1 decline in Cystic Fibrosis, Am J Respir Crit at: www.fibrosicisticaricerca.it/ (accessed 1 November candidates: 2006 update – a consensus report from the
Care Med, 2008;178:814–21. 2008). pulmonary scientific council of the International Society
12. Miall LS, McGinley NT, Brownlee KG, et al., Methicillin 29. Chongtrakool P, Ito T, Ma XX, et al., Staphylococcal for Heart and Lung Transplantation, J Heart Lung Transplant,
resistant Staphylococcus aureus (MRSA) infection in cystic cassette chromosome mec (SCCmec) typing of 2006;25:745–55.
fibrosis, Arch Dis Child, 2001;84:160-162. methicillin-resistant Staphylococcus aureus strains isolated 47. Macfarlane M, Leavy A, McCaughan J, et al., Successfull
13. Campana S, Cocchi P,Döring G, et al., Emergence of an in 11 Asian countries: a proposal for a new decolonization of methicillin-resistant Staphylococcus
epidemic clone of community-associated methicillin- nomenclature for SCCmec elements, Antimicrob Agents aureus in paediatric patients with cystic fibrosis (CF)
resistant panton-valentine leucocidin negative Chemother, 2006;50:1001–12. using a three-step protocol, J Hosp Infect, 2007;65:
Staphylococcus aureus in cystic fibrosis patient 30. Ito T, Okuma K, Ma XX, et al., Insights on antibiotic 231–36.
populations, J Clin Microbiol, 2007;45:3146. resistance of Staphylococcus aureus from its whole 48. Recommendations for preventing the spread of
14. Elizur A, Orscheln RC, Ferkol TW, et al., Panton-valentine genome: genomic island SCC, Drug Resist Updat, vancomycin resistance. Recommendations of the
leucocidin-positive methicillin resistant Staphylococcus 2003;6:41–52. Hospital Infection Control Practices Advisory Committee
aureus lung infection in patients with cystic fibrosis, 31. Aires de Sousa M, de Lencastre H, Evolution of sporadic (HICPAC), MMWR Recomm Rep, 1995;44(RR-12):1–13.
Chest, 2007;131:1718–25. isolates of methicillin-resistant Staphylococcus aureus 49. LeBlanc L, Pépin J, Toulouse K, et al., Fluoroquinolones
15. Community Associated MRSA information for Clinicians, (MRSA) in hospitals and their similarities to isolates of and risk for methicillin-resistant Staphylococcus aureus,
Infection control topics, Centers for Disease Control and community-acquired MRSA, J Clin Microbiol, 2003;41: Canada, Emerg Infect Dis, 2006;12:1398–1405.
Prevention, last modified February 3, 2005. Available at: 3806–15. 50. Moellering RC, Current treatment options for
www.cdc.gov/ncdod/dhqp/ar_mrsa_ca_clinicians.html 32. Okuma K, Iwakawa K, Turnidge JD, et al., Dissemination community-acquired methicillin-resitant Staphylococcus
(accessed 1 November 2008). of new methicillin-resistant Staphylococcus aureus clones aureus infection, Clin Infect Dis, 2008;46:1032–7.
16. Chambers HF, The changing epidemiology of Stafilococcus in the community, J Clin Microbiol, 2002;40:4289–94. 51. Cystic Fibrosis Trust, Antibiotic treatment for cystic
aureus?, Emerg Infect Dis, 2001;7:178–82. 33. Baba T, Takeuchi F, Kuroda M, et al., Genome and fibrosis, Report of the UK Cystic Fibrosis Trust Antibiotic
17. Sakoulas G, Moellering RC, Incresing antibiotic virulence determinants of high virulence community- Group . Available at:
resistance mong methicillin-resistant Staphylococcus acquired MRSA, Lancet, 2002;359:1819–27. www.cysticfibrosismedicine.com/htmldocs/CFText/Antib
aureus strains, Clin Infect Dis, 2008;46:360–67. 34. Coombs GW, Nimmo GR, Bell JM, et al., Australian Group ioticRx.pdf (accessed 1 November 2008).
18. Harbarth S, Francois P, Schrenzel J,et al., Community- for Antimicrobial Resistance, Genetic diversity among 52. Saiman L, Siegel J, Cystic Fibrosis Foundation. Infection
associated methicillin-resistant Staphylococcus aureus, community methicillin-resistant Staphylococcus aureus control recommendations for patients with cystic
Switzerland, Emerg Infect Dis, 2005;11:962–5. strains causing outpatient infections in Australia, J Clin fibrosis: microbiology, important pathogens, and
19. Borer A, Gilad J, Yagupsky P, et al., Community-acquired Microbiol, 2004;42:4735–43. infection control practices to prevent patient-to-patient
methicillin-resistant Staphylococcus aureus in 35. Tenover FC, McDougal LK, Goering RV, et al., transmission, Infect Control Hosp Epidemiol, 2003 ;24
institutionalized adults with developmental disabilities, Characterization of a strain of community-associated (Suppl. 5):S6–52.
Emerg Infect Dis, 2002;8:966–70. methicillin-resistant Staphylococcus aureus widely 53. Siegel JD, Jackson L, Chiarello M, Management of
20. Fritz SA, Garbutt J, Elward A, et al., Prevalence of and disseminated in the United States, J Clin Microbiol, Multidrug-Resistant Organisms In Healthcare Settings,
risk factors for community-acquired methicillin-resistant 2006;44:108–18. 2006 CDC. Available at: www.cdc.gov/ncidod/dhqp/pdf/
and methicillin-sensitive Staphylococcus aureus 36. Cookson BD, Robinson DA, Monk AB, et al., Evaluation of ar/mdroguideline2006.pdf (accessed 1 November 2008).
colonization in children seen in a practice-based molecular typing methods in characterizing a European 54. Festini F, Buzzetti R, Bassi C, et al., Isolation measures
research network, Pediatrics, 2008;121:1090–98. collection of epidemic methicillin-resistant Staphylococcus for prevention of infection with respiratory pathogens in
21. Vandenesch F, Naimi T, Enright MC, et al., Community- aureus strains: the HARMONY collection, J Clin Microbiol, cystic fibrosis: a systematic review, J Hosp Infect, 2006;64:
acquired methicillin-resistant Staphylococcus aureus 2007;45:1830–37. 1–6.
carrying Panton-Valentine leukocidin genes: worldwide 37. Enright MC, Day NP, Davies CE, et al., Multilocus 55. Pittet D, Hugonnet S, Harbarth S, et al., Effectiveness of
emergence, Emerg Infect Dis, 2003,9:978–84. sequence typing for characterization of methicillin- a hospital-wide programme to improve compliance with
22. Stryjewski ME, Chambers HF, Skin and soft-tissue resistant and methicillin-susceptible clones of hand hygiene, Lancet, 2000;356:1307–12.
58 EUROPEAN RESPIRATORY DISEASE
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68